On December 6, Ever Fortune.AI announced its partnership with Varian, China Medical University, Kaohsiung Veterans General Hospital, and Tungs’ Taichung MetroHarbor Hospital to develop an AI Adaptive Radiotherapy Platform. This platform leverages real-time data analysis to dynamically adjust treatment plans, enhancing precision and minimizing side effects during radiotherapy.
AI Adaptive Radiotherapy: A Step Forward in Personalized Cancer Treatment
AI adaptive radiotherapy represents a significant advancement in personalized and precision cancer treatment. By using AI, CT or MRI imaging can be segmented rapidly, offering recommendations on radiation dose and distribution. This reduces patient waiting times and allows medical teams to focus on more complex clinical decisions. After therapy, AI assists hospitals in analyzing patient recovery data, enabling early predictions of recurrence or side effects, thus facilitating timely interventions and improved patient care.
Strong Financial Performance and Regulatory Achievements
Ever Fortune.AI has demonstrated robust operational growth, with cumulative revenue reaching NT$312 million in the first 11 months of the year, a 312% year-on-year increase, despite recording a net loss of NT$0.05 per share in the first three quarters. The company has secured a total of 41 medical device certifications, including 15 from Taiwan’s TFDA, 11 from the U.S. FDA, and 15 from other countries. These certifications cover applications such as ECG, chest X-rays, RT organ auto-contouring, brain hemorrhage detection, aortic dissection, pediatric bone age analysis, bone scintigraphy, and myocardial perfusion.
Advanced Pediatric Growth Assessment System
Ever Fortune.AI’s Pediatric Growth Assessment System integrates multidimensional data such as bone age, height, weight, and BMI to generate time-trend reports that monitor and track children’s growth. This system helps identify conditions like delayed or precocious development early. The core of this system is its FDA- and TFDA-approved bone age interpretation software, available in cloud-based versions for small- to medium-sized clinics and localized versions for larger hospitals. It can also be customized to integrate with existing PACS systems in hospitals.
Intelligent Health Check Scheduling System
The company has also developed an Intelligent Health Check Scheduling System, which uses genetic algorithms and simulated annealing algorithms combined with AI to optimize health check schedules in just 10 seconds. This system reduces the average waiting time for patients by up to 31%, improving equipment utilization and patient satisfaction. The system notifies patients of their health check procedures and items via mobile devices. Health check supervisors can monitor the status of each station in real-time through a command room interface, allowing for quick adjustments to eliminate bottlenecks. Insights from this system also inform resource allocation and equipment investments, prioritizing stations with frequent delays.
With its advancements in AI-driven medical solutions, Ever Fortune.AI is setting a new standard in precision medicine and operational efficiency for healthcare providers worldwide.
Resource: 瞄準AI醫療商機 長佳智能結盟醫院打造放射治療平台
